Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant and Paroxetine in Major Depressive Disorder
NCT00413023Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of casopitant in major depressive disorder (MDD), sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
casopitant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00413023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413023.